URIS

Live / Applied — Non-final action mailed (as of 06 Mar 2026)

What this means for you

Not registered yet, but its 04 Jul 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79430358
Mark type
Stylized text
Filed
04 Jul 2025

Goods and services

  • Class 009 — Scientific and electric apparatus: Electrodes and devices for neurostimulation for scientific and research purposes; electrodes used for neuromodulation or electroceuticals treatment in the field of urology, neurology, gynecology, neurodegenerative, infertility, diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; pulse generators used for neuromodulation or electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; downloadable or online computer software for use in the design and use of medical instruments and devices used in neuromodulation or electroceuticals treatment or therapy
  • Class 010 — Medical apparatus: Medical apparatus and instruments used for neuromodulation or electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; medical devices used for neuromodulation or electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; electrodes for medical use used for neuromodulation or electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; medical electrodes and medical devices for use in either of neuromodulation, electro-stimulation or electroceuticals treatment and therapy; medical instruments and devices for use in either of electroceuticals or neuromodulation treatment and therapy
  • Class 042 — Scientific and technological services: Design, engineering, research, development and testing services for medical, scientific and technological applications in the field of neuromodulation or electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; design and development of medical instruments and devices for use in neuromodulation or electroceuticals treatment and therapy; technology research in the field of medical instruments and devices for use in neuromodulation or electroceuticals treatment and therapy; medical and scientific research services in the field of neuromodulation or electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; medical and scientific research in the fields of urology, neurology, gynecology, infertility, overactive bladder, neurodegenerative diseases, and chronic diseases using neuromodulation or electroceuticals treatment and therapy; providing medical and scientific research information in the fields of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; research and development of technology in the field of healthcare and medical devices, namely in the field of neuromodulation or electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; development of technology in the field of medical instruments and devices for neuromodulation or electroceuticals treatment and therapy; design and development of computer software; software as a service (SAAS) services featuring software for use in the design and use of medical instruments and devices used in neuromodulation or electroceuticals treatment and therapy; providing temporary use of on-line non-downloadable software for use in the design and use of medical instruments and devices used in neuromodulation or electroceuticals treatment and therapy
  • Class 044 — Medical, beauty and agricultural services: Medical services in the field of neuromodulation or electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; healthcare services in the field of neuromodulation or electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; medical services in the fields of urology, neurology, gynecology, infertility, neurodegenerative diseases, overactive bladder, and chronic diseases using electroceuticals or neuromodulation treatment and therapy; medical consultancy; providing medical information in the fields of urology, neurology, gynecology, infertility, neurodegenerative diseases, overactive bladder, and chronic diseases using electroceuticals or neuromodulation treatment and therapy; medical treatment of low urinary tract disfunction, parkinson's diseases, alzheimer's diseases, bowel disfunction, epilepsy, migraine and infertility using electroceuticals or neuromodulation treatment or therapy; rental of medical instruments and devices for use in electroceuticals or neuromodulation therapy

Owner

Prosecution history

  • 26 Mar 2026 — REFUSAL PROCESSED BY IB
  • 06 Mar 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
  • 06 Mar 2026 — REFUSAL PROCESSED BY MPU
  • 06 Feb 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
  • 05 Feb 2026 — NON-FINAL ACTION WRITTEN
  • 31 Jan 2026 — ASSIGNED TO EXAMINER
  • 30 Jan 2026 — APPLICATION FILING RECEIPT MAILED
  • 30 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 12 Sept 2025 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
  • 14 Aug 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB

View this trademark record on Marksy